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a b s t r a c t
During embryogenesis, lymphatic endothelial progenitor cells ﬁrst arise from a subset of blood vascular
endothelial cells in the dorsolateral aspects of the cardinal veins. The molecular cues responsible for
deﬁning the regionalisation of such a discrete pool of progenitors remain uncharacterised. Here we
identify a novel function for CYP26B1, an enzyme known to play a role in tissue morphogenesis by ﬁne-
tuning retinoic acid (RA) concentration, in regulating lymphangiogenesis. Cyp26b1-null mice, in which
RA levels are elevated, exhibited an increased number of lymphatic endothelial progenitor cells in the
cardinal veins, together with hyperplastic, blood ﬁlled lymph sacs and hyperplastic dermal lymphatic
vessels. Conversely, mice over-expressing Cyp26b1 had hypoplastic lymph sacs and lymphatic vessels.
Our data suggest that RA clearance by CYP26B1 in the vicinity of lymphatic endothelial progenitor cells is
important for determining the position and size of the progenitor pool speciﬁed. Our studies identify a
genetic pathway that underpins the architecture of the developing lymphatics and deﬁne CYP26B1 as a
novel modulator of lymphatic vascular patterning.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The lymphatic vasculature is a highly specialized circulatory
system that maintains ﬂuid homeostasis, facilitates immune cell
trafﬁcking and mediates lipid absorption from the digestive tract
(Alitalo et al., 2005). Similar to the blood vasculature, the lympha-
tic vasculature is a highly branched network comprised of initial
lymphatic vessels, pre-collector and collecting vessels which
function co-ordinately to return interstitial ﬂuid and protein to
the bloodstream (Tammela and Alitalo, 2010). To date, the identity
and cellular sources of signals that direct morphogenesis of the
lymphatic vasculature are poorly understood.
Lymphangiogenesis initiates at around 9.0 days post coitum (dpc)
in the mouse embryo, in a subpopulation of endothelial cells located
in the anterior region of the cardinal veins. Recent identiﬁcation of
key transcription factors that drive lymphatic endothelial cell fate
speciﬁcation has increased our understanding of the early steps in
lymphatic vascular development (lymphangiogenesis) at a molecular
level (Wigle et al., 2002; Wigle and Oliver, 1999; Yang et al., 2012).
The speciﬁcation of lymphatic endothelial cell fate is dependent on
the transcription factors SOX18 and COUP-TFII (Francois et al., 2008;
Srinivasan et al., 2010) that directly activate transcription of the
homeobox transcription factor gene Prox1. PROX1 is both necessary
and sufﬁcient to re-specify blood endothelial cells into lymphatic
endothelial cells (Hong et al., 2002; Petrova et al., 2002; Wigle et al.,
2002). The expression of Prox1 in venous endothelial cells deﬁnes a
pool of lymphatic endothelial progenitor cells that ultimately give
rise to the initial lymphatic vascular plexus and lymph sacs via a
combination of migrating streams of lymphatic endothelial cells
(LECs) (Francois et al., 2012; Hagerling et al., 2013; Yang et al.,
2012) and ballooning of small clusters of progenitors (Francois et al.,
2012). Expression of Sox18 and Prox1 is only activated in endothelial
cells on the dorsolateral side of the cardinal veins, but the identity of
the inducing or repressing factor(s) that ensure this asymmetric
distribution of lymphatic endothelial cell precursors is not known
(see for review Francois et al., 2011; Oliver and Srinivasan, 2010).
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Gradients of retinoic acid (RA) play pleiotropic roles during
development and are essential to control somitogenesis and left/
right symmetry of vertebrate embryos (Niederreither and Dolle,
2008). In tissues where RA plays an instructive role, the magnitude
of RA signal received by cells is under the control of the coordinated
expression of RA-synthesising enzymes (retinaldehyde dehydro-
genases; RALDH1, -2 and -3) and RA-catabolising enzymes (cyto-
chrome P450 enzymes; CYP26A1, -26B1 and -26C1). Previous
studies have shown that loss of Cyp26b1 function is lethal and
results in severe malformations affecting limb, craniofacial and
epidermal development (Yashiro et al., 2004). The ﬁrst link between
RA signalling and the lymphoid system was made by Mebius and
colleagues, who demonstrated that RA signalling plays a key role in
the initiation of lymph node development via the induction of
CXCL13 expression (van de Pavert et al., 2009). Given that lymph
nodes develop in close spatial association with the developing
lymphatic vasculature, it raises the possibility that the RA axis
may also play a role in patterning the lymphatic vasculature.
Recent work investigating the effects of RA on mouse embryoid
bodies and cultured human LECs in vitro has shown that RA
induces the expression of lymphatic endothelial cell markers in
embryoid body vascular differentiation assays and promotes the
proliferation and migration of hLECs (Choi et al., 2012; Marino
et al., 2011). In addition, the exposure to high RA levels during
development has been shown to promote lymphangiogenesis in
mouse and Xenopus embryos (Marino et al., 2011) and in vivo in a
mouse model of secondary lymphoedema (Choi et al., 2012). These
data suggest that RA signalling is likely to play an important role in
developmental lymphangiogenesis in vivo, though the dependence
on this signalling axis and the genetic mechanisms involved
remain to be investigated.
In the present study, we reveal a novel function for Cyp26b1 in
modulating initial morphogenetic events important for lymphatic
vascular development in the mouse embryo. Detailed character-
isation of Cyp26b1 expression combined with analysis of the RA
reporter transgenic mouse model RARE-LacZ, revealed that LEC
progenitors in the cardinal veins are exposed to relatively low
levels of RA during embryogenesis, due to the actions of CYP26B1.
Loss of function of Cyp26b1, resulting in higher levels of RA,
resulted in embryonic phenotypes characterised by generalised
edema and blood-ﬁlled lymphatic vessels. Excessive RA signalling
resulted in an increased population of lymphatic endothelial
progenitor cells speciﬁed in the embryonic cardinal veins and,
concomitantly, enlarged lymph sacs and a hyperplastic lymphatic
vascular plexus. Conversely, Cyp26b1 over-expression in a trans-
genic mouse model resulted in a reduced pool of lymphatic
endothelial progenitor cells and hypoplastic jugular lymph sacs,
revealing that RA levels need to be tightly regulated in vivo to
direct normal development of the lymphatic vasculature.
Materials and methods
Mouse strains
Mouse embryos were obtained from inter-crosses of Cyp26b1þ /
mice (Yashiro et al., 2004) and collected at different time points.
Staging was performed by somite count or, for later-stage embryos,
days post detection of a vaginal plug. PROX1-EGFP BAC transgenic
mice (Tg(Prox1-EGFP)221Gsat/Mmcd) were purchased from the
Mutant Mouse Regional Resource Centre, The Jackson Laboratory
(Choi et al., 2011). To test the effect of overexpressing the
RA-degrading enzyme CYP26B1 in embryos, we generated a
single-copy doxycycline-inducible Cyp26b1-overexpressing trans-
genic line using a method previously described (Beard et al.,
2006). Brieﬂy, a minimal CMV promoter driving the coding region
of mouse Cyp26b1 was introduced downstream of the Col1a1 locus
in KH2 ES cells by frt/FLPe recombinase-mediated site-speciﬁc
integration. The transgene is inducible by doxycycline due the
presence of the M2rtTA transactivator driven from the Rosa26 locus.
Studs (C57Bl/6) harbouring the Cyp26b1 transgene and homozygous
for the Rosa26-M2rtTA locus were mated with wildtype C57Bl/6
females and the pregnant females were orally dosed with doxycy-
cline (2 mg/ml together with 10 mg/ml of sucrose in water bottles)
beginning at 8.5 dpc. Litters were collected at 14.5 dpc and con-
tained approximately half wild-type and half transgenic progeny.
Cyp26b1 was strongly up-regulated by doxycycline treatment as
expected. Double transgenic mice Cyp261 /:Prox1-gfp embryos
were obtained by backcrossing the Cyp26b1þ / mouse into the
Prox1-gfp background. All procedures involving animals conformed
to institutional guidelines (University of Queensland and SA Pathol-
ogy/CHN Animal Ethics Committees).
Optical projection tomography
Stained embryos were embedded in warm 1% low-melting-
point agarose and left until set, adjusting the orientation as
necessary. Set agarose blocks were glued to aluminium mounts.
Specimens were then dehydrated in 50% methanol for 18 h with
3 graduated changes of methanol to 100%, and then cleared
overnight in benzyl alcohol:benzyl benzoate mixed at a ratio of
1:2. Once clear, samples were imaged in a Bioptonics 3001 OPT
scanner (Bioptonics, UK). Images were acquired at 0.91 intervals
and reconstructed. Stacks were rendered for presentation using
Imaris software.
Immunoﬂuorescence
Embryos were dissected and ﬁxed overnight in 4% PFA and
cryosections were cut as previously described (Wilhelm et al.,
2005). Primary antibodies in blocking solution (100 mM Maleic
acid, 10% horse serum, 1% DMSO in PBS-Triton-X 0.1%) were added
and incubated for 24 h at 4 1C. Samples were washed for 6 h in
washing solution (100 mM Maleic acid, 1% DMSO in PBS-Triton-X
0.1%) and incubated for 16 h with secondary antibodies in blocking
solution. Whole mount immunostaining of 10.0–11.5 dpc embryos
for confocal microscopy analysis was performed as follows: using
sharpened tungsten needles, embryos were bisected along the
longitudinal axis through the midline. Samples were washed twice
in PBS/Triton-X-100 0.3%, incubated for at least 2 h in blocking
solution (PBS/Triton X-100 0.3%/1% bovine serum albumin) and
then overnight at 4 1C in primary antibody diluted in blocking
solution. Samples were washed ﬁve times for 1 h each in PBS/
Triton X-100 0.3% at room temperature and then incubated over-
night at 4 1C with secondary antibodies in blocking solution.
Samples were washed for 5 h in PBS/Triton X-100 0.3% at room
temperature, then overnight at 4 1C and ﬁxed for 30 min (4%
formaldehyde in PBS). For visualization, embryos were dehydrated
in a graded series of methanol and cleared in benzyl alcohol:
benzyl benzoate overnight. Images were captured using a Zeiss
LSM 700 confocal microscope (Zeiss Laboratories). Images were
compiled using ZEN (blue edition) version 1.0 (Carl Zeiss) and
Adobe Photoshop CS5 version 12.0 (Adobe) software.
Antibodies
Antibodies were used in the following dilutions: rabbit poly-
clonal anti-mouse PROX1 (Angiobio), 1:1000; chicken polyclonal
anti-GFP (Sapphire Bioscience); 1:250, rabbit polyclonal anti-
mouse LYVE-1 (Angiobio), rat anti-mouse CD31 (BD Pharmingen)
1:500; rat monoclonal anti-PECAM antibody (BD Pharmingen),
1:200; hamster polyclonal anti-Podoplanin (Fitzgerald Industries,
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Concord. MA), 1:500; hamster polyclonal anti-ICAM antibody
(CD54) (Millipore, Australia) 1:200; goat polyclonal anti-Neuropi-
lin-2, goat polyclonal anti-mouse VE-Cadherin (R&D Systems)
1:500; rat monoclonal anti-endomucin (Santa Cruz Biotechnology
Inc) 1:500; rabbit polyclonal anti-CYP26B1 (Protein Tech™, USA)
1:100; rat monoclonal anti-mouse Foxc2 1:1000 (Furumoto et al.,
1999). Secondary antibodies anti-rat IgGAlexa 555, anti-rat IgGA-
lexa 488, anti-rabbit IgGAlexa 488, anti-hamster IgGAlexa 488,
anti-rat IgGAlexa 647, anti-mouse IgGAlexa 594, anti-goat Alexa
647, anti-goat Alexa555, anti-rabbit IgGAlexa 555 and anti-rabbit
IgGAlexa 647 (Molecular Probes) were used at 1:200 or 1:500 for
whole mount immunostaining.
Histology
Embryos for histological examination were ﬁxed in 4% paraf-
ormaldehyde at 4 1C overnight and embedded in parafﬁn or OCT.
Blocks were then sectioned (6–10 mm) and stained with haema-
toxylin and eosin.
Proliferation assay
Proliferation assays were performed using the CellTiter 96s
AQueous One Solution Cell Proliferation Assay reagent (Promega),
as per manufacturer0s instructions. All experiments were per-
formed in 96 well plates with 4–6 replicates. Brieﬂy, mouse
embryonic LEC were freshly isolated as previously described
(Kazenwadel et al., 2012), diluted to 1105 cells ml1 in EGM-
2 MV (Lonza) and 0.1 ml of cells was added to each well. Plates
were cultured at 37 1C/5% CO2 for 16–18 h. Cells were then
incubated in EGM-2MVþ0.1% DMSO v/v or EGM-2MV containing
RA (10 μM) (Sigma) and 0.1% DMSO v/v for 48 h. Cell proliferation
was measured following the addition of CellTiter 96s AQueous
One Solution Cell Proliferation Assay reagent (0.02 ml) to each well
and incubation for a further 4 h. Absorbance was measured at
490 nm on a FLUOstar OPTIMA microplate reader (BMG LABTECH).
Quantitative RT-PCR (qRT-PCR) analysis
Duplicate assays were carried out on an ABI Prism 7500
Sequence Detector System and the mean relative level of expres-
sion and associated SEM were calculated. Taqman gene expression
sets were as follows: Mm00446973_m1 (Tbp, endogenous control,
encoding TATA box binding protein), Mm00558507_m1 (Cyp26b1)
and Mm01319677_m1 (RAR-AR13).
Results
The venous endothelium and lymphatic endothelial progenitor cells
express different RA metabolic enzymes
Two recent studies (Choi et al., 2012; Marino et al., 2011)
suggested that all-trans and 9-cis RA could inﬂuence the early
stages of lymphatic vascular development in both mouse and
Xenopus embryos, prompting us to investigate in detail the
expression pattern and function of key enzymes that regulate
the synthesis and degradation of RA with respect to the early
stages of lymphangiogenesis. Using in situ hybridization and
immunoﬂuorescence to investigate the expression of Cyp26b1
(RA catabolic enzyme) on transverse sections of 11.5 dpc wild type
and lymphatic reporter Prox1-gfp embryos, we found that the
Cyp26b1 gene was expressed in a polarised fashion on the dorsal
side of the cardinal veins where PROX1-positive cells are speciﬁed
(Fig. 1A, black arrows and 1B, white arrows) suggesting that RA is
being degraded speciﬁcally in that region. This was further
validated on coronal sections; PROX1-positive LEC precursors in
the venous wall were also positive for CYP26B1 (Fig. 2A).
To further characterise the potential levels of RA in the cardinal
vein region of the embryo we also explored the expression pattern
of Aldh1a2 (encoding a major RA anabolic enzyme), by in situ
hybridisation. In contrast to Cyp26b1, Aldh1a2was observed on the
ventral aspect of the cardinal veins, opposite the location of LEC
progenitors (Wigle and Oliver, 1999) (Fig. 1C, red arrows). We also
took advantage of a transgenic reporter mouse which harbours a
retinoic acid responsive element driving the beta-galactosidase
gene (RARE-LacZ), enabling RA responsive tissues to be visualised
(Rossant et al., 1991). In accord with the expression of RA synthesis
and catabolism enzymes, beta-galactosidase activity was detected
in the Aldh1a2-positive region suggesting that RA signalling is
active in the ventro-medial side of the cardinal vein (Fig. 1D, black
arrows), but not in the region where PROX1-positive cells arise
(Fig. 1D asterisks). Further, immunostaining for PROX1, ENDOMU-
CIN and beta-galactosidase on 11.5 dpc RARE-LacZ transgenic
embryos demonstrated that LEC progenitor cells are not respon-
sive to RA signalling (Supplemental Fig. 1).
Finally, characterisation using double in situ and immunoﬂuor-
escence analysis validated the expression of Cyp26b1 (black) in the
vicinity of PROX1- positive (red) lymphatic endothelial cell pro-
genitors in coronal sections of 11.5 dpc wild type embryos (Fig. 2B,
white arrows). Immunohistochemistry for PROX1 (Fig. 2C, black)
or LYVE1 (Fig. 2D, brown) on coronal sections of 11.5 dpc RARE-
LacZ embryos further conﬁrmed the absence of RA signalling
(blue, framed box) in the vicinity of PROX1-positive lymphatic
endothelial progenitor cells (bracket).
Taken together, these observations suggest that during devel-
opment in vivo, the regions of the cardinal veins in which PROX1
expression is induced are exposed to low levels of RA signalling,
whereas the non-lymphangiogenic parts of the venous endothe-
lium are exposed to higher RA concentrations.
Proper regionalisation of PROX1 positive lymphatic endothelial
progenitor cells in the cardinal veins depends on CYP26B1 activity
Our observation that the dorso-lateral and ventral aspects of
the cardinal veins are exposed to low and high RA concentrations
respectively, prompted us to further explore the role of this
signalling pathway in regulating the size of the PROX1-positive
lymphatic endothelial progenitor cell pool speciﬁed in the veins.
Here we used the Cyp26b1 knock-out mouse model, considered
the gold standard to study interference of RA metabolism during
development (Bowles et al., 2006; Yashiro et al., 2004).
We ﬁrst investigated the distribution of lymphatic endothelial
progenitor cell markers PROX1 and LYVE1 in the walls of the
cardinal veins in the presence of excessive RA levels in Cyp26b1/
mouse embryos (Yashiro et al., 2004). Coronal sections of 11.5 dpc
embryos stained with PROX1 (red) or LYVE1 (red) showed a clear
organisation of PROX1-positive lymphatic endothelial progenitor
cells along the antero-posterior axis of the vein in wild-type
embryos (Fig. 3A and D, brackets indicate LEC progenitors). By
contrast, in Cyp26b1 / animals, the distribution of PROX1þ and
LYVE1þ LEC progenitor cells was expanded to the ventral and
medial aspects of the cardinal veins (Fig. 3B and E, white arrows).
These results suggest that elevated levels of RA, prior to 11.5 dpc,
disrupt the regionalisation of LEC progenitors.
To further investigate lymphatic endothelial progenitor cell spe-
ciﬁcation in Cyp26b1 / embryos, we backcrossed the Prox1-gfp
reporter mouse (Choi et al., 2011) onto the Cyp26 / background,
generating double transgenic mice in which we could visualize GFPþ
LECs in a setting of excessive RA levels. Characterisation of GFPþ LEC
progenitor distribution in this setting (Fig. 3C, white arrows) recapi-
tulated the abnormal distribution of endogenous PROX1 in the
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Cyp26b1 / background (Fig. 3B) and conﬁrmed the numerical and
spatial expansion of the PROX1-positive LEC progenitor pool in
Cyp26b1 / mice. PROX1 expression was also assessed on transverse
sections of Cyp26b1 / embryos, revealing that the distribution of
LEC progenitors in the cardinal veins was expanded on the ventro-
medial side. Immunoﬂuorescence for PROX1 (red) and VEGFR3 (blue)
(Supplemental Fig. 2A and B,) or LYVE1 (red), podoplanin (green) and
the pan-endothelial cell marker PECAM (blue) (Supplemental. Fig. 2C
Fig. 2. LEC progenitors in the veins are exposed to low RA levels. (A) Immunoﬂuorescence for CYP26B1 on coronal sections of 11.5 dpc Prox1-gfp transgenic embryos
revealed the expression of CYP26B1 enzyme (blue) in GFP-positive LEC precursors in the cardinal vein and developing lymph sacs. (B). Double in situ hybridisation and
immunoﬂuorescence for Cyp26b1 and Prox1 revealed the likely presence of the RA-degrading enzyme near LEC progenitors. (C and D) Beta-galactosidase staining of coronal
section of RARE-LacZ reporter embryo at 11.5 dpc revealed that lymphangiogenic territories in the cardinal vein (Prox1þ and LYVEþ) are devoid of RA signal (bracket, LEC
prog.). By contrast the medial side of the vein close to the dorsal aorta shows active RA signalling (framed box). DA, dorsal aorta; CV, cardinal vein; LS, lymph sac. Scale bars
A–C 50 μm.
Fig. 1. Expression of genes encoding an RA-degrading enzyme, Cyp26b1, and an RA-synthesising enzyme, Aldh1a2, is polarized in the cardinal vein. (A) In situ
hybridisation on transverse sections of 11.5 dpc embryo revealed the expression of Cyp26b1 mRNA on the dorso-lateral side of the cardinal vein (arrows).
(B) Immunoﬂuorescence for CYP26B1 on transverse sections of 11.5 dpc Prox1-gfp transgenic embryos demonstrates co-expression of CYP26B1 (arrow) in GFP-positive
LEC precursors. (C) Aldh1a2 is expressed in a polarised manner in the ventral side of the cardinal vein opposed to lymphangiogenic territories (red arrows). (D) RARE-LacZ
reporter staining further conﬁrmed the lack of RA signal in the lateral side of the cardinal vein (asterisks) and the presence of active RA signalling on the ventro-medial side
(black arrows). DA, dorsal aorta; CV, cardinal vein; LS, lymph sac; H, heart. Scale bars, A, B and C 100 μm and D 150 μm.
J. Bowles et al. / Developmental Biology 386 (2014) 25–3328
and D, asterisks) validated the ectopic distribution of LEC precursors
throughout both dorso-lateral and ventro-medial aspects of the
cardinal veins in Cyp26b1 / embryos. Conversely, the size of the
developing cardinal veins did not appear to be dramatically affected
by the change of RA concentration in vivo: the overall morphology
and size of the veins was unaffected in Cyp26b1 / embryos
(Supplemental Fig. 3).
In order to determine whether this change in regionalisation of
PROX1þ LEC in Cyp26b1 / embryos is a result of RA acting to
promote LEC progenitor cell speciﬁcation or proliferation, we
investigated the number of PROX1-positive precursor cells in
embryonic cardinal veins at 11.5 dpc, prior to any edema. Analysis
revealed that Cyp26b1-null embryos displayed an increase in
the pool of venous LEC precursors (Supplemental Fig. 2E and F).
Further, we examined the effects of RA on primary lymphatic
endothelial cells isolated from embryonic mouse skin. Exposure
of cells to 10 μM RA signiﬁcantly promoted LEC proliferation
(Supplemental Fig. 2G).
No changes in levels of Prox1 mRNA were observed in either
primary embryonic LECs or blood endothelial cells (BECs) treated
with RA (data not shown), suggesting that the effects of excess RA
on lymphatic vascular morphogenesis are likely due to the
promotion of LEC proliferation, shortly after their speciﬁcation.
Loss of Cyp26b1 function promotes the development of hyperplastic,
blood ﬁlled deep and superﬁcial lymphatics due to defective lympho-
venous valve patterning
To assess whether RA acts as a molecular cue that inﬂuences
morphogenesis of the primitive lymphatic vascular network, we
investigated lymphatic endothelial cell sprouting from the cardinal
veins, together with lymph sac formation, in Cyp26b1 / mice by
whole mount immunostaining (11.5 dpc and 13.5 dpc, Figs. 3
and 4) and staining of transverse sections through the jugular
lymph sacs (14.5 dpc) (Fig. 4). At 11.5 dpc, Cyp26b1/ embryos
had enlarged lymph sacs compared to wild type embryos (Fig. 3F–
K, dotted lines). Double transgenic Prox1-gfp::Cyp26b1 mice were
also used to analyze lymph sac development in vivo. Optical
projection tomography (OPT) and 3D rendering analyses revealed
that lymph sac volumes were enlarged in Cyp26b1 mutant
embryos compared to control littermates (Fig. 4A and B, blue
signal and Supplemental movies 1 and 2).
Fig. 3. Loss of Cyp26b1 function triggers disruption of the polarised distribution of LECs in the cardinal vein. (A and B) Immunoﬂuorescence on coronal sections of
11.5 dpc embryos revealed that the domain of PROX1-positive, Podoplanin-negative LEC progenitor cells in the cardinal veins is expanded in Cyp26b1 mutants (white
arrows). (C) Double transgenic animals Prox1-gfp::Cyp26b1 also displayed a lack of LEC progenitor organisation as observed on coronal sections of 11.5 dpc embryos. (D and
E) Immunoﬂuorescence for lymphatic speciﬁc marker LYVE1 and PODOPLANIN on coronal section further validated the aberrant distribution of LEC progenitors in the walls
of the cardinal veins. (F–K) Whole mount immunoﬂuorescence on 11.5 dpc bisected embryos using lymphatic-speciﬁc markers LYVE1 (blue) and PROX1 (red) revealed
enlarged lymph sacs in Cyp26b1/ embryos (I–K) compared to wild type embryos (F–H). PDP, PODOPLANIN; CV, cardinal vein; LS, lymph sac; LEC prog., lymphatic
endothelial cell progenitor; DA, dorsal aorta. Scale bars, A–E 100 μm; F–K 250 μm.
J. Bowles et al. / Developmental Biology 386 (2014) 25–33 29
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2013.12.008.
At 13.5 dpc, Cyp26b1/ embryos appeared haemorrhagic: an
accumulation of blood was apparent in the region of the devel-
oping jugular lymph sacs (Fig. 4C and D white arrow). At 14.5 dpc
and 16.5 dpc, Cyp26b1/ embryos exhibited pronounced subcu-
taneous edema and their superﬁcial lymphatics appeared to be
ﬁlled with blood (Fig. 4E and F and Supplemental Fig. 2). This
observation was conﬁrmed at 14.5 dpc by histological analysis of
transverse sections through the jugular region of wild type and
mutant embryos (Fig. 4G and H). Molecular characterisation using
lymphatic speciﬁc markers PROX1 (data not shown) or LYVE1
(Fig. 4I and J) with Podoplanin and the pan-endothelial cell marker
PECAM, revealed that signiﬁcant enlargement of the developing
lymph sacs persisted in Cyp26b1 / embryos at this develop-
mental stage. Quantitation of lymph sac diameter in wild type and
mutant embryos conﬁrmed that the jugular lymph sacs were
enlarged as a result of Cyp26b1 loss of function (Fig. 4K).
Analysis of the skin of Prox1-gfp::Cyp26b1 / embryos at
14.5 dpc revealed striking differences in the morphology of the
dermal lymphatic vasculature compared to that of their wild type
littermates (Fig. 5A and B). Lymphatic vessels in mutant embryos
were increased in diameter and were substantially less branched.
By contrast, the blood vasculature, stained with antibodies to
endomucin (Fig. 5A and B, red) did not display any patterning
defects, suggesting that RA acts selectively on the lymphatic vessel
network at the developmental stages characterised.
With a view to identifying the cause of blood-ﬁlled lymphatics,
we analysed development of the lymphovenous valves that are
responsible for proper separation of the blood and lymphatic
vascular networks. During development, these valves separate
the jugular and subclavian veins from the jugular lymph sacs
and are characterised by high levels of PROX1 and FOXC2 expres-
sion (Srinivasan and Oliver, 2011) (Fig. 5 C–F, box). In Cyp26b1 /
embryos, the lymphovenous valves were expanded in size and
exhibited elevated FOXC2 levels (Fig. 5G J, arrows). These defects
likely underlie the phenotype of blood-ﬁlled lymphatics in
Cyp26b1/ embryos.
Gain of Cyp26b1 function disrupts proper patterning
of lymphatic vessels
Having shown that excess RA is detrimental to the orderly
distribution and number of lymphatic endothelial progenitors and
to the patterning of lymphatic vessels, the next step was to
determine the effect of reduced RA dosage in vivo. To that end,
we generated a transgenic mouse that can be induced to over-
express Cyp26b1 under the control of a CMV promoter. To conﬁrm
elevated Cyp26b1 expression, we performed qRT-PCR analysis on
embryonic tissue dissected from the jugular area where lymph
sacs are known to develop (Fig. 6A) and analysed expression levels
of RAR-beta, as an indirect readout for RA concentration (Fig. 6B):
Fig. 4. Loss of Cyp26b1 function induces a severe lymphatic vascular pheno-
type. (A and B) OPT processing and 3-D rendering of bisected Prox1-gfp embryos
after whole mount immunoﬂuorescence for GFP (blue) and Endomucin (white)
showed that lymph sacs of Cyp26b1 / embryos are enlarged compared to control
littermates. The ﬁrst six inter-somitic vessels are indicated in red, the blue
rendering is outlining the total surface area of lymph sacs in wild type and mutant
embryos. (C and D) Gross morphology observation revealed edema and blood
vascular leakage into the jugular lymph sacs of Cyp26b1 / embryos at 13.5 dpc
(white arrowhead). (E and F) At 14.5 dpc, developing lymphatics are blood-ﬁlled
and histology analysis (G and H) conﬁrmed the presence of red blood cells in the
lymph sacs. (I-J) Immunoﬂuorescence analysis for lymphatic speciﬁc markers
LYVE1 (red) and PODOPLANIN (green) and the pan-endothelial cell marker PECAM
further validated the presence of enlarged lymph sacs in the Cyp26b1/ embryos
at 14.5 dpc. In some cases cells single positive for PODOPLANIN were observed on
the medial side of the vein, this cell population corresponds to undifferentiated
neurons in the neural tube. (K) Quantitation of lymph sac diameter comparing wild
type control and Cyp26b1 / embryos at 13.5 dpc. Mutant embryos showed a
signiﬁcant enlargement of jugular lymph sacs. CA, carotid artery; JV, jugular vein;
LS, lymph sac. Scale bars A and B 250 μm, C–F 500 μm and G–J 200 μm. Statistical
analysis no0.05 (p¼0.0285), non-paired t-test, (n¼4 for each genotype, 3 serial
sections per animal).
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as expected, this established RA target was down-regulated in
Cyp26b1-transgenic embryos. Following Cyp26b1 over-expression
at 8.5 dpc, transgenic embryos exhibited substantially smaller
jugular lymph sacs than their wild type counterparts at 14.5 dpc
(Fig.6C–F), suggesting that too little RA is also deleterious for
lymphatic vascular development. Taken together, these results
show that a ﬁnely-tuned dosage of RA is critical for proper
morphogenesis of the initial lymphatic vascular network in vivo.
Discussion
The molecular basis for the earliest step in lymphatic develop-
ment, the polarised distribution of lymphatic endothelial progeni-
tor cells in the embryonic cardinal veins, has remained a mystery.
Here we present evidence that the well-studied developmental
morphogen, RA, is asymmetrically available to endothelial cells of
the cardinal veins, with high levels present on the ventral side and
lower levels on the dorsal side, where LEC progenitors are
speciﬁed. The asymmetry is set up by the polarised expression
around the vein of genes encoding an RA-synthesising enzyme,
ALDH1a2, and an RA-degrading enzyme, CYP26B1. By examining
Cyp26b1 / and Cyp26b1-overexpressing embryos, we reveal that
tightly regulated RA levels are essential for normal lymphatic
development.
Key ﬁndings of this study are: (1) By 11.5 dpc, the genes that
encode enzymes involved in RA catabolism and anabolism are
expressed in deﬁned domains of the embryonic cardinal veins;
(2) In the setting of elevated RA levels (Cyp26b1/), the size of
the PROX1-positive lymphatic endothelial progenitor cell pool in
the embryonic cardinal veins is increased as early as 11.5 dpc;
(3) Hyperplastic, blood ﬁlled lymph sacs and lymphatic vessels are
a feature of Cyp26b1/ embryos and conversely, lymph sacs are
hypoplastic in embryos that express high levels of Cyp26b1, in
which RA levels are diminished; (4) Elevated RA levels trigger
lymphovenous valve malformations and (5) Hyperplasia of lymph
sacs and lymphatic vessels in Cyp26b1 / embryos occurs, at least
in part, due to the promotion of LEC proliferation by RA. This work
has identiﬁed a novel molecular cue that is essential to the proper
morphogenesis of the lymphatic vascular tree.
Lymphangiogenesis and RA metabolism
A role for RA in lymphangiogenesis has recently been suggested
by two studies showing that exposure of developing embryos to
supra-physiological doses of RA increased the number of PROX1-
positive LEC precursor cells in mouse and Xenopus embryos
(Marino et al., 2011) and that RA promoted lymphatic vascular
regeneration in a mouse model of lymphedema (Choi et al., 2012).
Our ﬁndings that disruption of the gene encoding the CYP26B1
enzyme, resulting in elevated RA levels, leads to an increase in size
of the LEC progenitor pool, as well as in hyperplasia of lymph sacs
and dermal lymphatic vessels in Cyp26b1/ mice, is in agreement
with these studies. Our work also suggests that the phenotype of
blood ﬁlled jugular lymph sacs and dermal lymphatic vessels
characteristic of Cyp26b1/ embryos is due to the defective
development of lymphovenous valves (Srinivasan and Oliver,
2011). Whether this is the result of a role for RA in valve
speciﬁcation, or due to elevated numbers of PROX1-positive cells
in the embryonic veins, remains to be investigated.
The molecular role of RA signalling
Recent work has shown that the nuclear orphan receptor
COUP-TFII is able to directly drive Prox1 transcription to induce
lymphatic endothelial cell differentiation (Srinivasan et al., 2010).
Although an endogenous ligand for COUP-TFII remains to be
determined, a previous study has identiﬁed COUP-TFII as a low-
afﬁnity RA-activated receptor (Kruse et al., 2008). Taken together,
these observations raise the possibility that RA might modify
COUP-TFII activity, either directly or indirectly, via interaction with
nuclear RA receptors, which might in turn modulate the level of
Prox1 transcription and the number of LEC progenitor cells that are
speciﬁed. In keeping with the idea of direct action of RA on
endothelial cells of the cardinal vein, others have recently demon-
strated that BECs of the cardinal vein express the RAR-α receptor
(Marino et al., 2011). This concept is in line with previous ﬁndings
Fig. 5. Loss of Cyp26b1 function in vivo and in vitro induces impaired remodelling of superﬁcial lymphatics and hyper-proliferation of LECs. (A and B) Whole mount
immunoﬂuorescence of 14.5 dpc embryonic skin; utilisation of the pan-endothelial cell marker ENDOMUCIN (red) and the lymphatic speciﬁc marker neuropilin-2 (NRP2,
green) and GFP (blue) revealed that lymphatic vessels of the Cyp26b1 / embryos fail to assemble properly. By contrast, the blood vasculature remained unaffected. (C–J)
Immunoﬂuorescent immunostaining of lymphovenous valve markers PROX1 (red) and FOXC2 (green) with the pan-endothelial cell marker VE-cadherin (blue) on coronal
sections of 13.5 dpc wild type and Cyp26b1 / embryos demonstrated larger valve leaﬂets in the mutant mice (arrows). CV, cardinal vein, JLS, jugular lymph sac. Scale bars A
and B 200 μm, C–J 100 μm.
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from Lai and colleagues (Lai et al., 2003) showing that RA regulates
endothelial cell proliferation during vasculogenesis.
Genetic pathways that instruct morphogenesis of the lymphatic
vascular tree remain mostly unexposed. To date only a handful
of growth molecules such as vascular endothelial growth factor-c
(VEGF-C), angiopoeitin-1 or adrenomedullin have been shown as
essential to pattern the expanding lymphatic vasculature (Fritz-Six
et al., 2008; Karkkainen et al., 2004; Tammela et al., 2005). The
discovery of a signalling pathway that provides an asymmetric
morphogenetic cue to endothelial cells of the cardinal vein is there-
fore signiﬁcant and should help us to eventually understand how
lymphatic vessels initially assemble. Our work demonstrates that
physiologically-available RA must be present within a critical range in
order for lymphangiogenesis to begin normally and contributes new
genetic models that can be used to complement existing genetic tools
used in studying the birth of the lymphatic vasculature.
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embryos showed that transgenic animals over-express Cyp26b1 mRNA by 16-fold and that this is associated with a 3-fold lower expression of RARA-Rd. Statistical analysis:
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